# A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well

Study · id `cardio:ct-nct07361302` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07361302](<https://clinicaltrials.gov/study/NCT07361302>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07361302

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1325 participants.

## Technical summary

Registry record NCT07361302. Randomized; no masking; primary purpose treatment. Start 2026-02-17 (actual); primary completion 2027-10-02 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 1325 participants (planned count; ClinicalTrials.gov record NCT07361302, source copy `cardio:ctgov-nct07361302-2026-11-10`, retrieved 2026-11-18)
- Started: 2026-02-17 (actual) (ClinicalTrials.gov record NCT07361302, source copy `cardio:ctgov-nct07361302-2026-11-10`, retrieved 2026-11-18)
- Primary completion: 2027-10-02 (anticipated) (ClinicalTrials.gov record NCT07361302, source copy `cardio:ctgov-nct07361302-2026-11-10`, retrieved 2026-11-18)
- Completion: 2027-10-02 (anticipated) (ClinicalTrials.gov record NCT07361302, source copy `cardio:ctgov-nct07361302-2026-11-10`, retrieved 2026-11-18)
- Countries: Argentina; Australia; Bulgaria; China; Greece; Hungary; India; Indonesia; Kazakhstan; Malaysia; Norway; Romania; Spain; Taiwan; Thailand; Vietnam (ClinicalTrials.gov record NCT07361302, source copy `cardio:ctgov-nct07361302-2026-11-10`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07361302-2026-11-10`, retrieved 2026-11-18)

## The registry's words

- Brief title: A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well
- Acronym: TENACITY
- Condition: Acute Ischemic Stroke
- Intervention (Drug): Tenecteplase
- Intervention (Drug): Standard of care treatment
- Lead sponsor: Boehringer Ingelheim
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Tenecteplase (`cardio:tenecteplase`)
- Registry intervention is a member of this class by a sourced record link: Fibrinolytic (clot-dissolving) drugs (`cardio:fibrinolytic-clot-dissolving-drugs`)
- Registry lists this organization as the lead sponsor: Boehringer Ingelheim (`cardio:boehringer-ingelheim`)

## Provenance

Content hash: d2f8451ebf7bab1b89e002cc98ffd9c2febd591f97c78800e42a4873a6e9eb0b
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
